Articles by Glenn Engelmann - Pharmaceutical Executive

ADVERTISEMENT

Articles by Glenn Engelmann

As the Compliance Net Tightens...

Feb 1, 2012

Time to stop and think about CMS's 'Proposed Rule' on transparency and what it means for the life sciences business model.

ADVERTISEMENT

Click here